112 related articles for article (PubMed ID: 10505771)
21. BCL2 and JUNB abnormalities in primary cutaneous lymphomas.
Mao X; Orchard G; Lillington DM; Child FJ; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ
Br J Dermatol; 2004 Sep; 151(3):546-56. PubMed ID: 15377339
[TBL] [Abstract][Full Text] [Related]
22. Pathology of malignant lymphomas.
Kadin ME; Said JW
Curr Opin Oncol; 1990 Oct; 2(5):822-31. PubMed ID: 1965694
[No Abstract] [Full Text] [Related]
23. CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus.
Chadburn A; Cesarman E; Jagirdar J; Subar M; Mir RN; Knowles DM
Cancer; 1993 Nov; 72(10):3078-90. PubMed ID: 8221575
[TBL] [Abstract][Full Text] [Related]
24. Clusterin expression in malignant lymphomas: a survey of 266 cases.
Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
[TBL] [Abstract][Full Text] [Related]
25. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
26. [Molecular pathogenesis of peripheral T-cell lymphoma (1): angioimmunoblastic T-cell lymphoma, peripheral T-cell lymphoma, not otherwise specified and anaplastic large cell lymphoma].
Couronné L; Bastard C; Gaulard P; Hermine O; Bernard O
Med Sci (Paris); 2015 Oct; 31(10):841-52. PubMed ID: 26481023
[TBL] [Abstract][Full Text] [Related]
27. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene.
van der Krogt JA; Bempt MV; Ferreiro JF; Mentens N; Jacobs K; Pluys U; Doms K; Geerdens E; Uyttebroeck A; Pierre P; Michaux L; Devos T; Vandenberghe P; Tousseyn T; Cools J; Wlodarska I
Haematologica; 2017 Sep; 102(9):1605-1616. PubMed ID: 28659337
[TBL] [Abstract][Full Text] [Related]
28. Expression of anaplastic lymphoma kinase in non-Hodgkin's lymphomas and other malignant neoplasms. Biological, diagnostic, and clinical implications.
Wasik MA
Am J Clin Pathol; 2002 Dec; 118 Suppl():S81-92. PubMed ID: 14569815
[TBL] [Abstract][Full Text] [Related]
29. Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior.
McClure RF; Remstein ED; Macon WR; Dewald GW; Habermann TM; Hoering A; Kurtin PJ
Am J Surg Pathol; 2005 Dec; 29(12):1652-60. PubMed ID: 16327438
[TBL] [Abstract][Full Text] [Related]
30. Detection of the t(2;5)(p23;q35) chromosomal translocation in large B-cell lymphomas other than anaplastic large cell lymphoma.
Arber DA; Sun LH; Weiss LM
Hum Pathol; 1996 Jun; 27(6):590-4. PubMed ID: 8666370
[TBL] [Abstract][Full Text] [Related]
31. Some questions on the significance of chromosome alterations in leukemias and lymphomas: a review.
Neri G
Am J Med Genet; 1984 Jul; 18(3):471-81. PubMed ID: 6383040
[TBL] [Abstract][Full Text] [Related]
32. The relation of oncogenesis and cytogenetics in leukemia and lymphoma.
Pearson M; Rowley JD
Annu Rev Med; 1985; 36():471-83. PubMed ID: 3888062
[TBL] [Abstract][Full Text] [Related]
33. Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation.
Ngan BY; Chen-Levy Z; Weiss LM; Warnke RA; Cleary ML
N Engl J Med; 1988 Jun; 318(25):1638-44. PubMed ID: 3287162
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous anaplastic large cell lymphoma and peripheral T-cell lymphoma NOS show distinct chromosomal alterations and differential expression of chemokine receptors and apoptosis regulators.
van Kester MS; Tensen CP; Vermeer MH; Dijkman R; Mulder AA; Szuhai K; Willemze R; van Doorn R
J Invest Dermatol; 2010 Feb; 130(2):563-75. PubMed ID: 19710685
[TBL] [Abstract][Full Text] [Related]
35. The anaplastic variant of centrocytic lymphoma is marked by frequent rearrangements of the bcl-1 gene and high proliferation indices.
Ott MM; Ott G; Kuse R; Porowski P; Gunzer U; Feller AC; Müller-Hermelink HK
Histopathology; 1994 Apr; 24(4):329-34. PubMed ID: 8045522
[TBL] [Abstract][Full Text] [Related]
36. Oncogene expression in murine splenic T cells and in murine T-cell neoplasms.
Mally MI; Vogt M; Swift SE; Haas M
Virology; 1985 Jul; 144(1):115-26. PubMed ID: 2414915
[TBL] [Abstract][Full Text] [Related]
37. Peripheral T cell and natural killer (NK) T cell lymphomas: a clinicopathological study from a single Australian centre.
McKelvie PA; Thompson PA; Tam CS
Histopathology; 2012 Aug; 61(2):212-23. PubMed ID: 22716228
[TBL] [Abstract][Full Text] [Related]
38. Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge.
Boerma EG; Siebert R; Kluin PM; Baudis M
Leukemia; 2009 Feb; 23(2):225-34. PubMed ID: 18923440
[TBL] [Abstract][Full Text] [Related]
39. Oncogene involvement in lymphoid malignancy.
Ngan BY; Berinstein N
Tumour Biol; 1990; 11 Suppl 1():78-93. PubMed ID: 2247757
[TBL] [Abstract][Full Text] [Related]
40. PAX-5 Positivity in Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma: A Case Report and Review of Literature.
Arun I; Roy P; Arora N; Bhave SJ; Nair R; Chandy M
Int J Surg Pathol; 2017 Jun; 25(4):333-338. PubMed ID: 28013563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
